A novel method demonstrates efficient production of selenium-functionalized compounds, highlighting its broad substrate scope.
An approach has been developed for the direct synthesis of various selenium-functionalized benzo[4,5]imidazo[2,1-b][1,3]thiazine derivatives via the electrophilic cyclization reaction between 2-(methylthio)-1-(3-arylprop-2-yn-1-yl)-1H-benzo[d]imidazoles and diorganyl diselenides promoted by N-fluorobenzenesulfonimide (NFSI). This strategy is used to construct fused heterocyclic scaffolds based on selenium-functionalized 4H-benzo[4,5]imidazo[2,1-b][1,3]thiazines using NFSI as a stable and nonhazardous oxidizing agent in the presence of CH3CN at 80 °C. The protocol allowed a broad substrate scope leading to the synthesis of 16 novel selenium-functionalized benzo[4,5]imidazo[2,1-b][1,3]thiazines in yields of up to 95%. Furthermore, control studies, including 1H, 19F, and 77Se NMR experiments, were conducted to identify intermediates, which contributed to the elucidation of the reaction mechanism.
No takes yet. Share an insight, caveat, or question.
Bartz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: